COVID-19 vaccine hesitancy and willingness to pay: Emergent factors from a cross-sectional study in Nigeria

Adigwe, Obi Peter

doi:10.1016/j.jvacx.2021.100112

Cited by 47 publications

(69 citation statements)

References 46 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Social media such as WhatsApp, Facebook and Twitter are popular social media platforms where misinformation, and fake news are communicated and transmitted. Thus, sampling public opinion through these networks, is critical for public health planning [11,25,26]. Those who frequent the internet are more likely than others to be linked to networks outside their immediate locations (particularly abroad) and to be affected by online vaccine conspiracies coming from remote locations.…”

Section: Methodsmentioning

confidence: 99%

“…Vaccines designed to protect against Beta strains are less effective than those designed to protect against other strains. There was only 75% efficacy for Pfizer’s vaccine in clinical trials [18,25], whereas in South African trials, the AstraZeneca AZD1222 vaccine failed to prevent even mild or moderate COVID-19 infection [26]. Good neutralisation was seen with the Covaxin and NVX-CoV2373 (Covavax) vaccines.…”

Section: Introductionmentioning

confidence: 99%

“…Hesitancy to the COVID-19 vaccines could impede the success of vaccination programmes [25][26][27][28][29]. Also, the speed of COVID-19 vaccine development, registration and deployment in less than a year have contributed to the level of hesitancy in Africa [9].…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

COVID-19 vaccines uptake: Public knowledge, awareness, perception and acceptance among adult Africans

Ahiakpa

Cosmas

Anyiam

et al. 2022

Preprint

View full text Add to dashboard Cite

IntroductionThe willingness of Africa’s population to take the COVID-19 vaccines is critical to the efficiency of national immunisation programmes. This study surveys the views of adult African inhabitants toward vaccination and the possibility of participating or not participating in governments’ efforts to get citizens vaccinated.MethodA cross-sectional online survey of adult Africans was undertaken from December 2020 to March 2021. Responses were anonymised. The Pearson Chi-square test was performed to determine whether or not there were any variations in knowledge, awareness, perception and acceptance of the COVID-19 vaccines among the participants. Binomial logistic regression was used to evaluate the factors associated with willingness to accept COVID-19 vaccines and participate in immunisation programmes.ResultsThe results indicate that COVID-19 vaccines are more likely to be used by adult Africans over the age of 18 who are largely technologically savvy (55 percent) if the vaccine is made broadly available. A total of 33 percent of those who responded said they were unlikely to receive the vaccine, with another 15 percent stating they were undecided. Aside from that, we found that vaccine hesitancy was closely associated with socio-demographic characteristics such as age, gender, education and source of information. We also found that there were widespread conspiracies and myths about the COVID-19 vaccines.ConclusionMore than two-thirds of African adults who participated in the survey indicated they would not receive the COVID-19 vaccine, with majority of them expressing skepticisms about the vaccine’s efficacy. It is possible that many of the people who would not be vaccinated would have an impact on the implementation of a COVID-19 immunisation programme that is meant for all of society. Majority of the respondents were unwilling to pay for the COVID-19 vaccines when made available. An awareness campaign should be focused on promoting the benefits of vaccination at the individual and population levels, as well as on taking preemptive actions to debunk misconceptions about the vaccines before they become further widespread.

show abstract

Section: Methodsmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

COVID-19 vaccines uptake: Public knowledge, awareness, perception and acceptance among adult Africans

Ahiakpa

Cosmas

Anyiam

et al. 2022

Preprint

View full text Add to dashboard Cite

show abstract

“…For example, the study in Pakistan [13] showed the median of WTP was USD 7, while the study in Pakistan [14] showed the median of WTP was USD 3.13. Meanwhile, the WTP result in Nigeria [15] and Nigeria [16] were both USD 1.2 but in Nigeria [17] was USD 13.…”

Section: Wtp Measure For Vaccines In Low and Middle Income Countriesmentioning

confidence: 99%

“…The most common reason for refusing vaccination based on the study was worry about the safety of the vaccine. Otherwise, studies that were performed in Nigeria (3 studies) have the range of USD 1.2 -13.16 [15][16][17].…”

Section: Fig 3 the Relative Magnitude Of Wtp Values For Low-middle-in...mentioning

confidence: 99%

Willingness-To-Pay for COVID-19 Vaccine in Low and Middle-Income Countries Compared to High-Income Countries: A Systematic Review

Yuliani

Kristina

Endarti

2022

JPRI

View full text Add to dashboard Cite

Aims: By focusing largely on lower-income countries, this study adds to the evolving worldwide picture of willingness to pay for COVID19 vaccination. Willingness-To-Pay (WTP) values for the pandemic COVID-19 vaccine, which provide monetary indicators of community preferences for vaccines, could help policymakers in low- and middle-income countries determine priorities for health resource utilization. Study Design: Systematic Review. Methodology: A systematic review of the study on willingness to pay for COVID-19 vaccine in the Pubmed, Science Direct, and Scopus through January 2022 was performed to find relevant articles published between January 2020 and January 2022. Following PRISMA guidelines, the study yielded 19 English-language studies (12 studies in low- and middle-income countries, 2 in high-income countries, and 5 in upper-middle-income countries) that evaluated WTP for COVID-19 vaccines, either existing or hypothetical vaccines. All WTP values extracted were converted to 2021 United States Dollars (USD) for comparability Results: This study showed that the willingness to pay in low-middle-income countries varied from USD 1.2 to USD 85.92. Studies conducted in the same country might have different WTP values. Average WTP in low-income countries have lower WTPs than high and upper-middle-income countries. In addition to being in line with differences in GDP, cases and deaths from COVID-19 in high-income countries are higher than in low-income countries. Conclusion: From low-middle income countries evaluation, the high value of WTP is not consistently aligned with the high value of GDP per capita from each country. The finding demonstrates that the factors that affect the value of WTP are not only the GDP per capita of the country. The perception of risk, the WTP evaluation method used, and several other factors that need to be studied further also affect the amount of WTP.

show abstract

Decolonising vaccine production: Unpacking Ghanaians’ support for made-in-Africa vaccines

et al. 2023

View full text Add to dashboard Cite

COVID-19 vaccine hesitancy and willingness to pay: Emergent factors from a cross-sectional study in Nigeria

Cited by 47 publications

References 46 publications

COVID-19 vaccines uptake: Public knowledge, awareness, perception and acceptance among adult Africans

COVID-19 vaccines uptake: Public knowledge, awareness, perception and acceptance among adult Africans

Willingness-To-Pay for COVID-19 Vaccine in Low and Middle-Income Countries Compared to High-Income Countries: A Systematic Review

Decolonising vaccine production: Unpacking Ghanaians’ support for made-in-Africa vaccines

Contact Info

Product

Resources

About